EL.PA · PAR · Healthcare
EssilorLuxottica Société anonyme
Also onConsensus Drift
Implied value per share
EUR 141.11
Market price
EUR 139.00
Implied upside
+1.5%
5-year forecast · Perpetuity growth terminal value · Mid-year discounting · Base case
Value Per Share
Same forecast, different terminal treatment. Percentages vs price.
Forecast Cashflows
Reporting currency (EUR). Outflows negative.
| Line | FY26 | FY27 | FY28 | FY29 | FY30 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | EUR 30.0bn | EUR 31.5bn | EUR 33.1bn | EUR 34.9bn | EUR 36.7bn | +5.2% |
| EBIT | EUR 3.8bn | EUR 4.0bn | EUR 4.2bn | EUR 4.4bn | EUR 4.6bn | +5.2% |
| NOPAT | EUR 2.9bn | EUR 3.0bn | EUR 3.2bn | EUR 3.3bn | EUR 3.5bn | +5.2% |
| Add depreciation & amortisation | EUR 3.4bn | EUR 3.6bn | EUR 3.8bn | EUR 4.0bn | EUR 4.2bn | +5.2% |
| Less capital expenditure | EUR -1.8bn | EUR -1.9bn | EUR -2.0bn | EUR -2.1bn | EUR -2.2bn | +5.2% |
| Less increase in working capital | EUR -750.1m | EUR -788.8m | EUR -829.6m | EUR -872.5m | EUR -917.5m | +5.2% |
| Free cashflow to firm | EUR 3.8bn | EUR 4.0bn | EUR 4.2bn | EUR 4.4bn | EUR 4.6bn | +5.2% |
| Discount factor | 0.9692 | 0.9103 | 0.8550 | 0.8031 | 0.7543 | - |
| Present value | EUR 3.7bn | EUR 3.6bn | EUR 3.6bn | EUR 3.5bn | EUR 3.5bn | -1.2% |
| Present Value Of The Forecast | EUR 17.9bn | |||||
Discount Rate
Source shown per component. All overridable above.
| Risk-free rate | 3.20% | EUR assumption - no free live source available for this market (assumption) |
| Equity risk premium | 6.00% | Market assumption |
| Beta | 0.696 | Reported 0.546, pulled toward 1.0 (Blume) |
| Cost of equity | 7.37% | Risk-free + beta x equity risk premium |
| Cost of debt | 3.20% | Floored at the risk-free rate (implied cost of debt was lower) |
| Market capitalisation | EUR 63.8bn | 81.6% of capital |
| Total debt | EUR 14.4bn | 18.4% of capital, book value as a proxy |
| Tax rate | 23.9% | Effective, capped at statutory |
| WACC | 6.46% | E/V x Re + D/V x Rd x (1 - t) |
Terminal Value
Perpetuity growth is intrinsic. The exit multiple defaults to the company's current EV/EBITDA, so it answers a different question - what the shares are worth if today's rating holds and EBITDA grows as forecast.
Perpetuity growth at 2.50%
77% of EV
- Forecast FCFF, final year
- EUR 4.6bn
- Capex at depreciation, working capital in reinvestment
- EUR 4.9bn
- Less reinvestment at g/ROIC (38.7% of NOPAT)
- EUR -1.9bn
- Capitalised
- EUR 3.0bn
- ROIC (WACC floor)
- 6.5%
- Terminal value, undiscounted
- EUR 77.5bn
- Terminal value, discounted
- EUR 58.5bn
- Enterprise value
- EUR 76.4bn
- Less net debt
- EUR 10.9bn
- Equity value
- EUR 65.6bn
Exit at 11.5x EBITDA
81% of EV
- Terminal value, undiscounted
- EUR 101.7bn
- Terminal value, discounted
- EUR 76.8bn
- Enterprise value
- EUR 94.7bn
- Less net debt
- EUR 10.9bn
- Equity value
- EUR 83.8bn
Spread between methods: 24%.
Sensitivity
Value per share (EUR) by discount rate and long-run growth.
| Long-run growth | |||||
|---|---|---|---|---|---|
| Discount rate | 1.50% | 2.00% | 2.50% | 3.00% | 3.50% |
| 4.46% | 227.30 | 236.61 | 250.24 | 272.61 | 317.29 |
| 5.46% | 170.00 | 170.76 | 171.51 | 172.27 | 173.03 |
| 6.46% | 139.88 | 140.50 | 141.11 | 141.72 | 142.34 |
| 7.46% | 117.86 | 118.37 | 118.88 | 119.39 | 119.90 |
| 8.46% | 101.07 | 101.50 | 101.93 | 102.36 | 102.79 |
Outlined: this model. Green text: above today's price of 139.00. Shading: distance from this model's own value.
Priced In
What each input would have to be to justify the current price, one at a time.
| Input | Model | Implied | Gap |
|---|---|---|---|
| Revenue growth, every year | 5.2% | 4.8% | -0.4pp |
| EBIT margin | 12.6% | 12.3% | -0.2pp |
| Discount rate | 6.5% | 6.5% | +0.1pp |
Live formulas, not pasted numbers - edit a driver and the workbook reprices.
Yahoo Finance and RBA data. General information, not advice. Methodology.